iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Shares Bought by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC raised its stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 4.1% during the fourth quarter, Holdings Channel reports. The firm owned 6,699 shares of the company’s stock after purchasing an additional 261 shares during the period. Janney Montgomery Scott LLC’s holdings in iShares U.S. Pharmaceuticals ETF were worth $440,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. US Bancorp DE boosted its holdings in shares of iShares U.S. Pharmaceuticals ETF by 137.0% in the 3rd quarter. US Bancorp DE now owns 384 shares of the company’s stock valued at $27,000 after purchasing an additional 222 shares during the last quarter. Assetmark Inc. boosted its holdings in shares of iShares U.S. Pharmaceuticals ETF by 100.0% in the 3rd quarter. Assetmark Inc. now owns 432 shares of the company’s stock valued at $31,000 after purchasing an additional 216 shares during the last quarter. Allworth Financial LP boosted its holdings in shares of iShares U.S. Pharmaceuticals ETF by 9.4% in the 3rd quarter. Allworth Financial LP now owns 1,853 shares of the company’s stock valued at $131,000 after purchasing an additional 159 shares during the last quarter. EP Wealth Advisors LLC acquired a new position in shares of iShares U.S. Pharmaceuticals ETF in the 3rd quarter valued at $157,000. Finally, Farther Finance Advisors LLC boosted its holdings in shares of iShares U.S. Pharmaceuticals ETF by 97.1% in the 3rd quarter. Farther Finance Advisors LLC now owns 2,482 shares of the company’s stock valued at $175,000 after purchasing an additional 1,223 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Stock Down 0.5 %

Shares of IHE opened at $70.05 on Monday. The firm has a market cap of $707.51 million, a PE ratio of 6.49 and a beta of 0.58. The company’s fifty day moving average is $67.36 and its two-hundred day moving average is $69.12. iShares U.S. Pharmaceuticals ETF has a fifty-two week low of $62.67 and a fifty-two week high of $72.94.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.